Short Communication
A cellular and bioinformatics analysis of the SENP1 SUMO isopeptidase in pancreatic cancer
Journal of Gastrointestinal Oncology
2019;
10
(5)
:821-830
.
(01 October 2019)
Original Article
Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy
Journal of Gastrointestinal Oncology
2019;
10
(5)
:831-840
.
(01 October 2019)
Treatment delays during FOLFOX chemotherapy in patients with colorectal cancer: a multicenter retrospective analysis
Journal of Gastrointestinal Oncology
2019;
10
(5)
:841-846
.
(01 October 2019)
Identification of potential biomarkers and pathways in ulcerative colitis with combined public mRNA and miRNA expression microarray data analysis
Journal of Gastrointestinal Oncology
2019;
10
(5)
:847-858
.
(01 October 2019)
Loss of ferrochelatase is protective against colon cancer cells: ferrochelatase a possible regulator of the long noncoding RNA H19
Journal of Gastrointestinal Oncology
2019;
10
(5)
:859-868
.
(01 October 2019)
Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database
Journal of Gastrointestinal Oncology
2019;
10
(5)
:869-877
.
(01 October 2019)
Decreased percentage of neutrophil is a predict factor for the efficacy of trifluridine and tipiracil hydrochloride for pretreated metastatic colorectal cancer
Journal of Gastrointestinal Oncology
2019;
10
(5)
:878-885
.
(01 October 2019)
Effect of KRAS mutational status on disease behavior and treatment outcome in patients with metastatic colorectal cancer: intratumor heterogeneity and mutational status
Journal of Gastrointestinal Oncology
2019;
10
(5)
:886-895
.
(01 October 2019)
Rectal cancer in the young: analysis of contributing factors and surgical outcomes
Journal of Gastrointestinal Oncology
2019;
10
(5)
:896-901
.
(01 October 2019)
Accuracy of nodal staging is influenced by sidedness in colon cancer
Journal of Gastrointestinal Oncology
2019;
10
(5)
:902-909
.
(01 October 2019)
First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: a good choice beyond age
Journal of Gastrointestinal Oncology
2019;
10
(5)
:910-917
.
(01 October 2019)
Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma
Journal of Gastrointestinal Oncology
2019;
10
(5)
:918-927
.
(01 October 2019)
Does the addition of adjuvant intraoperative tumor bed chemotherapy during midgut neuroendocrine tumor debulking procedures benefit patients?
Journal of Gastrointestinal Oncology
2019;
10
(5)
:928-934
.
(01 October 2019)
Clinical outcomes of endoscopic submucosal tunnel dissection compared with conventional endoscopic submucosal dissection for superficial esophageal cancer: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2019;
10
(5)
:935-943
.
(01 October 2019)
Phase Ib trial of gemcitabine with yttrium-90 in patients with hepatic metastasis of pancreatobiliary origin
Journal of Gastrointestinal Oncology
2019;
10
(5)
:944-956
.
(01 October 2019)
Delivery rate of patients with advanced gastric cancer to third-line chemotherapy and those patients’ characteristics: an analysis in real-world setting
Journal of Gastrointestinal Oncology
2019;
10
(5)
:957-964
.
(01 October 2019)
The prognostic value of systemic immune-inflammation index (SII) in patients after radical operation for carcinoma of stomach in gastric cancer
Journal of Gastrointestinal Oncology
2019;
10
(5)
:965-978
.
(01 October 2019)
Trends of incidence and survival in patients with gastroenteropancreatic signet ring cell carcinoma: an analysis from the Surveillance, Epidemiology, and End Results program
Journal of Gastrointestinal Oncology
2019;
10
(5)
:979-988
.
(01 October 2019)
Quality of life as a fundamental outcome after curative intent gastrectomy for adenocarcinoma: lessons learned from patients
Journal of Gastrointestinal Oncology
2019;
10
(5)
:989-998
.
(01 October 2019)
Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation
Journal of Gastrointestinal Oncology
2019;
10
(5)
:999-1009
.
(01 October 2019)
Case Report
Successful 5-fluorouracil (5-FU) infusion re-challenge in a metastatic colorectal cancer patient with coronary artery disease who experienced symptoms consistent with coronary vasospasm during first 5-FU infusion
Journal of Gastrointestinal Oncology
2019;
10
(5)
:1010-1014
.
(01 October 2019)
Asymptomatic esophageal glomus tumor: case report
Journal of Gastrointestinal Oncology
2019;
10
(5)
:1015-1020
.
(01 October 2019)
An unusual case of primary acinar cell carcinoma of the liver and its treatment
Journal of Gastrointestinal Oncology
2019;
10
(5)
:1021-1026
.
(01 October 2019)
A case of gastric small cell carcinoma with metastases to bone and liver
Journal of Gastrointestinal Oncology
2019;
10
(5)
:1027-1031
.
(01 October 2019)
